Non-Covalent Inhibitors of Rhinovirus 3C Protease.
Baxter, A., Chambers, M., Edfeldt, F., Edman, K., Freeman, A., Johansson, C., King, S., Morley, A., Petersen, J., Rawlins, P., Spadola, L., Thong, B., Poel, H.V., Williams, N.(2011) Bioorg Med Chem Lett 21: 777
- PubMed: 21183345 
- DOI: https://doi.org/10.1016/j.bmcl.2010.11.110
- Primary Citation of Related Structures:  
2XYA - PubMed Abstract: 
The first known non-covalent inhibitors of rhinovirus 3C protease (3CP) have been identified through fragment based screening and hit identification activities.
Organizational Affiliation: 
AstraZeneca, R&D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, UK.